## MOH: Molina Healthcare Inc - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 1.4% below STRENGTH zone (3.0-6.0%); PEG unavailable fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($140.90)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Norges Bank Buys Shares of 712,027 Molina Healthcare, Inc $MOH**
- Source: MarketBeat | 20251204T041026 | Neutral | Relevance: 99%
-  Norges Bank acquired a new position of 712,027 shares in Molina Healthcare, Inc. (NYSE:MOH) during the second quarter, valued at approximately $212.1 million. This investment represents about 1.31% of the company. Molina Healthcare recently missed its EPS consensus despite an 11% revenue increase, and its stock is currently trading down.

**2. Molina Has Dug A Narrow Moat in Its Government-Sponsored Plans**
- Source: Morningstar | 20251205T170837 | Bullish | Relevance: 99%
-  Morningstar has initiated coverage of Molina Healthcare Inc. with a "Narrow Moat" rating and a fair value estimate of $311. Molina specializes in government-sponsored medical insurance plans (Medicaid, Medicare, and individual exchanges), focusing on cost management to generate economic profits. This strategy appears to successfully secure business in its key markets.

**3. Molina Healthcare, Inc. (MOH): A Bull Case Theory**
- Source: Insider Monkey | 20251204T190910 | Somewhat-Bullish | Relevance: 99%
- This article summarizes a bullish thesis on Molina Healthcare, Inc. (MOH) from Sherwood Investment Letter, suggesting its stock is undervalued after a significant drop following Q3 results. Despite short-term pressures, Molina shows resilient fundamentals with 11% revenue growth and a defensive operating model in the Medicaid and Medicare space. The author posits the market's reaction is an overcorrection, presenting a potential investment opportunity similar to when Berkshire Hathaway invested in UnitedHealth.

**4. MOH Deadline Today: MOH Investors Have Opportunity to Lead Molina Healthcare, Inc. Securities Fraud Lawsuit**
- Source: Morningstar | 20251203T150925 | Neutral | Relevance: 98%
-  The Rosen Law Firm reminds investors who purchased Molina Healthcare, Inc. (NYSE: MOH) securities between February 5, 2025, and July 23, 2025, of the December 2, 2025, lead plaintiff deadline for a securities fraud lawsuit. The lawsuit alleges that Molina failed to disclose material adverse facts regarding its medical cost trend assumptions and financial guidance, leading to investors suffering damages. Investors can join the class action to potentially recover compensation without upfront fees.

**5. Molina Healthcare (MOH) Stock Is Up, What You Need To Know**
- Source: Finviz | 20251203T152700 | Neutral | Relevance: 98%
- Molina Healthcare (MOH) shares recently jumped 2.2% despite bearish commentary, rebounding from recent lows but still facing operational and financial pressures such as declining Medicaid membership and rising expenses. The stock's volatile movement followed a previous gain linked to potential extensions of Obamacare subsidies. Despite the recent uptick, MOH is significantly down year-to-date and from its 52-week high.

### Analyst Activity

**Target Signal:** VERY_BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-12 | Wells Fargo | $165 | $231 | -29% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-12 | Wells Fargo | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 8 ($0.44M) |
| Sells | 1 ($0.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 61.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.9% (+0.1%)
- Capital World Invest: 9.5% (-2.0%)
- Blackrock Inc.: 8.4% (-3.9%)
- Price (T.Rowe) Assoc: 6.5% (+58.8%)
- AQR Capital Manageme: 5.4% (+217.0%)

### Key Risks

1. Elevated short interest (10.0%): bears positioning against stock.
2. Long-term trend broken: trading 35.9% below SMA200.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- Momentum building: MRS_10 improving +1.9% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $8.5B |
| Beta | 0.52 |
| 52W Range | $133.40 - $359.97 |
| Short Interest | 10.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | -0.62 |
| Forward P/E | 10.8 |
| Current P/E | 10.7 |
| YoY Growth | -0.4% |
| EPS Direction | FALLING |

### Technicals

MRS_10 strengthening from -0.5% to 1.4% (+1.9% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.6pp (needs >3.0% for momentum thesis). MRS_5 at 1.7% confirms short-term momentum alignment. Outperforming sector by 3.8pp, stock-specific strength. Below SMA200 (0.64x), long-term trend not supportive. MACD histogram positive (2.62), confirming momentum. RSI neutral at 51.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.45% (CS: 68) | Neutral |
| RSI_14 | 51.1 | Neutral |
| MACD Histogram | 2.62 | Bullish |
| vs SMA20 | 1.056x | Above |
| vs SMA50 | 0.914x | Below |
| vs SMA200 | 0.641x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $151.86
- **Stop Loss:** $140.90 (7.2% risk)
- **Target:** $162.82 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 45
- **Position Value:** $6,833.70
- **Portfolio %:** 6.83%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite persisting. Mixed earnings signals with industrial weakness (John Deere) offset by consumer/tech strength, while institutional flows show selective positioning rather than broad risk-off. Fed meeting in 9 days provides near-term catalyst but current data suggests status quo maintenance.*

### Earnings

**Next:** 2026-02-04 (Est: $0.64)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.89 | $1.84 | -52.7% |
| 2025Q2 | $5.53 | $5.48 | -0.9% |
| 2025Q1 | $5.96 | $6.08 | +2.0% |
| 2024Q4 | $5.88 | $5.05 | -14.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*